Evaluation of the expression of the oncogen C-ERBB-2/HER2 in advanced gastric cancer cases from Costa Rica
Open Access
- 19 September 2019
- journal article
- research article
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 13, 962
Abstract
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epideKeywords
This publication has 15 references indexed in Scilit:
- HER2 testing in gastric cancer: a practical approachLaboratory Investigation, 2012
- Gastric HER2 Testing Study (GaTHER)American Journal of Surgical Pathology, 2012
- Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?Human Pathology, 2012
- HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the LiteratureJournal of Cancer, 2012
- HER-2/neuTesting and Therapy in Gastroesophageal AdenocarcinomaPathology Research International, 2011
- Anti-HER agents in gastric cancer: from bench to bedsideNature Reviews Gastroenterology & Hepatology, 2011
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biologyThe International Journal of Developmental Biology, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Assessment of a HER2 scoring system for gastric cancer: results from a validation studyHistopathology, 2008
- X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa RicaBritish Journal of Cancer, 2007